AN2 Therapeutics (ANTX) Earnings Date & Reports

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform... Show more

Industry: #Managed Health Care

Get AI intraday signals

A.I. Advisor

published Earnings

ANTX is expected to report earnings to fall 25.14% to -26 cents per share on August 07

AN2 Therapeutics ANTX Stock Earnings Reports

Q2'25

Est.

$-0.26

Q1'25

Missed

by $0.10

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.13

The last earnings report on May 13 showed earnings per share of -34 cents, missing the estimate of -25 cents. With 21.81K shares outstanding, the current market capitalization sits at 35.52M.

View a ticker or compare two or three

Compare

ANTX